CDC20 and hepatocellular carcinoma: In addition, studies that focused on abnormal DNA methylation in hepatocellular carcinoma have also shown that patients with hypomethylation and high expression of CDC20 had shorter overall survival and that this gene served as a novel biomarker for precision diagnosis and treatment32.